Page last updated: 2024-08-24

2',3'-dideoxycytidinene and Antibody Deficiency Syndrome

2',3'-dideoxycytidinene has been researched along with Antibody Deficiency Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hill, DL; Hoover, EA; Mullins, JI; Perigo, NA; Strobel, JD; Zeidner, NS	1

Other Studies

1 other study(ies) available for 2',3'-dideoxycytidinene and Antibody Deficiency Syndrome

Article	Year
Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2',3'-dideoxycytidine. Antiviral research, 1989, Volume: 11, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Monoclonal; Capsules; Cats; Dideoxynucleosides; Disease Models, Animal; Drug Implants; Drug Therapy, Combination; Gene Products, gag; Immunologic Deficiency Syndromes; Infusions, Intravenous; Injections, Subcutaneous; Interferon Type I; Leukemia Virus, Feline; Retroviridae Proteins; Tetrahydrouridine; Tumor Necrosis Factor-alpha; Virus Replication; Zalcitabine	1989

Article

Year

Treatment of FeLV-induced immunodeficiency syndrome (FeLV-FAIDS) with controlled release capsular implantation of 2',3'-dideoxycytidine.

Antiviral research, 1989, Volume: 11, Issue:3

Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Monoclonal; Capsules; Cats; Dideoxynucleosides; Disease Models, Animal; Drug Implants; Drug Therapy, Combination; Gene Products, gag; Immunologic Deficiency Syndromes; Infusions, Intravenous; Injections, Subcutaneous; Interferon Type I; Leukemia Virus, Feline; Retroviridae Proteins; Tetrahydrouridine; Tumor Necrosis Factor-alpha; Virus Replication; Zalcitabine

1989